Leighann Sherry

3.3k total citations · 2 hit papers
40 papers, 2.5k citations indexed

About

Leighann Sherry is a scholar working on Infectious Diseases, Epidemiology and Periodontics. According to data from OpenAlex, Leighann Sherry has authored 40 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 15 papers in Epidemiology and 14 papers in Periodontics. Recurrent topics in Leighann Sherry's work include Antifungal resistance and susceptibility (26 papers), Oral microbiology and periodontitis research (14 papers) and Fungal Infections and Studies (13 papers). Leighann Sherry is often cited by papers focused on Antifungal resistance and susceptibility (26 papers), Oral microbiology and periodontitis research (14 papers) and Fungal Infections and Studies (13 papers). Leighann Sherry collaborates with scholars based in United Kingdom, Netherlands and Italy. Leighann Sherry's co-authors include Gordon Ramage, Craig Williams, Ranjith Rajendran, Ryan Kean, Elizabeth M. Johnson, Riina Rautemaa‐Richardson, Christopher J. Nile, Malcolm Richardson, Andrew M. Borman and B Jones and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Leighann Sherry

39 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fungal Biofilm Resistance

2012 421 citations Gordon Ramage, Ranjith Rajendran et al. profile →
Biofilm-Forming Capability of Highly Virulent, Multidrug-ResistantCandida auris

2017 322 citations Leighann Sherry, Gordon Ramage et al. profile →

Peers

Countries citing papers authored by Leighann Sherry

Since Specialization

Citations

This map shows the geographic impact of Leighann Sherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leighann Sherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leighann Sherry more than expected).

Fields of papers citing papers by Leighann Sherry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leighann Sherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leighann Sherry. The network helps show where Leighann Sherry may publish in the future.

Co-authorship network of co-authors of Leighann Sherry

This figure shows the co-authorship network connecting the top 25 collaborators of Leighann Sherry. A scholar is included among the top collaborators of Leighann Sherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leighann Sherry. Leighann Sherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Microbe Profile: Candidozyma auris: an emergent and resilient yeast and new antifungal strategies 2026 ·Microbiology ·(unknown), Leighann Sherry, (unknown)	0
2	Cell Viability Assays for Candida auris 2022 ·Methods in molecular biology ·Jason L. Brown, Bryn Short, (unknown), Leighann Sherry, Ryan Kean, Gordon Ramage	6
3	Recurrent Vulvovaginal Candidiasis: a Dynamic Interkingdom Biofilm Disease of Candida and Lactobacillus 2021 ·mSystems ·Emily McKloud, Christopher Delaney, Leighann Sherry, Ryan Kean, (unknown), Rebecca Metcalfe, (unknown), Riina Rautemaa‐Richardson, Konstantinos Gerasimidis, Christopher J. Nile, Craig Williams, Gordon Ramage	49
4	Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence 2019 ·Journal of Hospital Infection ·Bryn Short, Jason L. Brown, Christopher Delaney, Leighann Sherry, Craig Williams, Gordon Ramage, Ryan Kean	67
5	The application of phenotypic microarray analysis to anti-fungal drug development 2017 ·Journal of Microbiological Methods ·Darren Greetham, David F. Lappin, Ranjith Rajendran, Lindsay E. O’Donnell, Leighann Sherry, Gordon Ramage, Christopher J. Nile	2
6	Implications of Antimicrobial Combinations in Complex Wound Biofilms Containing Fungi 2017 ·Antimicrobial Agents and Chemotherapy ·Eleanor R. Townsend, Leighann Sherry, Ryan Kean, (unknown), William G. Mackay, Craig Williams, John Butcher, Gordon Ramage	32
7	Viable Compositional Analysis of an Eleven Species Oral Polymicrobial Biofilm 2016 ·Frontiers in Microbiology ·Leighann Sherry, (unknown), Lindsay E. O’Donnell, Emma Millhouse, Owain R. Millington, David J. Bradshaw, (unknown), Craig Williams, Christopher J. Nile, Gordon Ramage	38
8	In Vitro Effect of Porphyromonas gingivalis Methionine Gamma Lyase on Biofilm Composition and Oral Inflammatory Response 2016 ·PLoS ONE ·(unknown), Emma Millhouse, Leighann Sherry, Joseph Aduse‐Opoku, Shauna Culshaw, Gordon Ramage, David J. Bradshaw, Gary R. Burnett, Robert P. Allaker	16
9	A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients 2016 ·Frontiers in Microbiology ·Ranjith Rajendran, Leighann Sherry, (unknown), Elizabeth M. Johnson, Mary Hanson, Craig Williams, Carol A. Munro, B Jones, Gordon Ramage	61
10	Integrating Candida albicans metabolism with biofilm heterogeneity by transcriptome mapping 2016 ·Scientific Reports ·Ranjith Rajendran, (unknown), Leighann Sherry, Ryan Kean, Craig Williams, B Jones, Karl Burgess, Jaap Heringa, Sanne Abeln, Bernd W. Brandt, Carol A. Munro, Gordon Ramage	38
11	Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection—Scotland, 2012–2013 2015 ·Clinical Microbiology and Infection ·Ranjith Rajendran, Leighann Sherry, Christopher J. Nile, Andrea Sherriff, Elizabeth M. Johnson, Mary Hanson, Craig Williams, Carol A. Munro, Brian Jones, Gordon Ramage	184
12	Extracellular DNA release confers heterogeneity in Candida albicans biofilm formation 2014 ·BMC Microbiology ·Ranjith Rajendran, Leighann Sherry, David F. Lappin, Christopher J. Nile, Karen Smith, Craig Williams, Carol A. Munro, Gordon Ramage	45
13	Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity 2014 ·BMC Microbiology ·Leighann Sherry, Ranjith Rajendran, David F. Lappin, Elisa Borghi, Federica Perdoni, Monica Falleni, Delfina Tosi, Karen Smith, Craig Williams, B Jones, Christopher J. Nile, Gordon Ramage	116
14	Utilising polyphenols for the clinical management of Candida albicans biofilms 2014 ·International Journal of Antimicrobial Agents ·Muhammad Shahzad, Leighann Sherry, Ranjith Rajendran, Christine A. Edwards, Emilie Combet, Gordon Ramage	89
15	Inhibitory effect of plant (poly)phenolics on growth and biofilm formation by Candida albicans 2014 ·Proceedings of The Nutrition Society ·Muhammad Shahzad, Leighann Sherry, Ranjith Rajendran, Christine A. Edwards, Emilie Combet, Gordon Ramage	3
16	Investigating the biological properties of carbohydrate derived fulvic acid (CHD-FA) as a potential novel therapy for the management of oral biofilm infections 2013 ·BMC Oral Health ·Leighann Sherry, Emma Millhouse, David F. Lappin, Colin Murray, Shauna Culshaw, Christopher J. Nile, Gordon Ramage	39
17	Antifungal, Cytotoxic, and Immunomodulatory Properties of Tea Tree Oil and Its Derivative Components: Potential Role in Management of Oral Candidosis in Cancer Patients 2012 ·Frontiers in Microbiology ·Gordon Ramage, Steven G. Milligan, David F. Lappin, Leighann Sherry, (unknown), Craig Williams, Jeremy Bagg, Shauna Culshaw	78
18	A Comparative In Vitro Study of Two Denture Cleaning Techniques as an Effective Strategy for Inhibiting Candida albicans Biofilms on Denture Surfaces and Reducing Inflammation 2012 ·Journal of Prosthodontics ·Gordon Ramage, (unknown), (unknown), Leighann Sherry, Colin Murray, (unknown), Zvi G. Loewy, Daryll C Jagger	30
19	Carbohydrate Derived Fulvic Acid: An in vitro Investigation of a Novel Membrane Active Antiseptic Agent Against Candida albicans Biofilms 2012 ·Frontiers in Microbiology ·Leighann Sherry, Anto Jose, Colin Murray, Craig Williams, B Jones, Owain R. Millington, Jeremy Bagg, Gordon Ramage	32
20	In Vitro Candida albicans Biofilm Induced Proteinase Activity and SAP8 Expression Correlates with In Vivo Denture Stomatitis Severity 2012 ·Mycopathologia ·Gordon Ramage, Brent J. Coco, Leighann Sherry, Jeremy Bagg, David F. Lappin	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact